In summary, TGF-β blockade, on one hand, polarizes the N2 pro-tumor phenotype of TANs to N1 anti-tumor phenotype, and on the other hand increases the expression of GM-CSF and IFN-γ in the tumor cells, which promotes the activity of TANs. The gene discussed is TGFB1; the disease is neoplasm.